期刊文献+

体外循环期间内源性NO水平的研究 被引量:2

Study of Intrinsic NO Levels during Cardiopulmonary Bypass
暂未订购
导出
摘要 目的 探讨体外循环对血管内皮依赖性舒张功能的影响及与肺动脉高压的关系。方法  2 0例置换双瓣病人 ,按术前肺动脉压分成二组 :肺高压组 (H)和正常组 (N) ,在体外循环前、体外循环后即刻及体外后 4、12h测基础状态、静注乙酰胆碱 (Ach)后和吸一氧化氮 (NO)w =2 0× 10 -6时的环鸟苷酸 (cGMP)水平。结果 体外循环使cGMP下降 ,12h后回升 ,以H组为明显 ;注射Ach及吸入NO都引起cGMP增加 ;N组cGMP水平受体外循环影响较H组轻 (分别为 12 .16~ 17.2 0和 4.45~ 13.73pmol/ml) ,而且吸入NO的影响较静注Ach影响更大。结论 伴肺高压的心瓣膜病患者血管内皮功能已处于减弱状态 ,其程度比正常肺动脉压者重 ,体外循环造成的血管内皮功能损伤在肺高压患者更为突出。 Purpose To study the impacts of cardiopulmonary bypass (CPB) on vascular endothelium dependent relaxation and the relations of CPB and pulmonary hypertension. Methods Twenty valvular rep lacing patients were tested.According to their preoperative pulmonary arterial pressure (PAP),these patients divided into pulmonary hypertension group (H) and normal group (N).Measure the concentrations of cGMP of basic condition,after acetylcholine(Ach) intravenation and during nitric oxide (NO) inhalation before the sternal split,after weaning from CPB immediately,the 4 hour and the 12 hour later. Results It was found that the concentrations of cGMP declined during CPB and resumed 12 hour after,especially in the H group Ach intravenation and NO inhalation increased releasing of cGMP,and level of cGMP was less influen ced by CPB in the N group than in the H group (12.16~17.12 and 4.45~13.73 pmol/ml respectively).It was also found that NO inhalation had more effects than Ach intravenation. Conclusions We concluded that the injury of vascular endothelium function caused by CPB was more critical in pulmonary hypertension patients.
出处 《上海医科大学学报》 CSCD 2000年第2期112-114,共3页 Journal of Fudan University(Medical Science)
基金 卫生部科学研究基金!( 96-2 -13 1)资助
关键词 内源性一氧化氮 体外循环 乙酰胆碱 intrinisic NO cardiopulmonary bypass acetylcholine
  • 相关文献

参考文献8

  • 11,Loscalzo J.Endothelial dysfunction in pulmonary hypertention.N Engl J Med,1992,327:117-120
  • 22,Koul B,Wollmer P,Willen H,et al.Venoarterial extracorporeal membrane oxygenation-how safe is it?J Thorac Cardiovasc Surg,1992,104:579-584
  • 33,Wheller J,George B,Muller D,et al.Diagnosis and management of postoperative pulmonary hypertensive crisis.Circulation,1980,60:1640-1649
  • 44,Journois D,Poward P,Mauriat P,et al.Inhaled nitric oxide as a therapy for pulmonary hypertention after operations for congenital heart defects.J Thorac Cardiovasc Surg,1994,107:1129-1135
  • 55,Abman S,Chatfield B,Hall S,et al.Role of EDRF during transition of pulmonary circulation at birth.Am J Physiol,1990,259:H1921-H1927
  • 66,Stamler JS,Loh E,Roddy MA.Nitric oxide regular basal systemic and pulmonary vascular resistance in healthy humans.Circulation,1994,89:2035-2040
  • 77,Vane JR,Anggad EE,Botting RM.Regulatory function of vascular endothelium.N Engl J Med,1990,323:27-36
  • 88,Seccombe JF,Pearson PJ,Schaff HV,et al.Oxygen radical mediated vascular injury selectively inhibits receptor dependent release of nit-ric oxide from canine coronary arteries.J Thorac Cardiovasc Surg,1994,107:505-509

同被引文献21

  • 1[1]Wan S,LeClerc JL,Vincent JL.Inflammatory response to cardiopulmonary bypass[J].Chest.1997;112:676.
  • 2[2]Hiramatsu T,Imai Y,Takanashi Y,et al.Time course of endothelin-1 and nitrate anion levels after ardiopulmonary bypass in congenital heart defects[J].Ann Thorac Surg.1997;63:648.
  • 3[3]Boyle EM Jr,Verrier ED,Spiess BD.Endothelial cell injury in cardiovascular surgery:the procoagulant response[J].Ann Thorac Surg.1996;62:1549.
  • 4[4]Jansen NJG,Van Oeveren W,et al.Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass[J].Ann Thorac Surg.1992;54:744.
  • 5[5]Rulovo G,Grexo E,Speziale G,et al.Nitric oxide formation during cardiopulmonary bypass[J].Ann Thorac Surg.1994;57:1005.
  • 6Grebenik CR, Robinson PN. Cardiac transplantation at Harefield. A review from the anesthetist′s standpoint. Anaesthesia, 1985, 40: 131-140.
  • 7Kriett JM, Kaye MP. The registry of the international society for heart transplantation: seventh official report-1990. J Heart Transplant, 1990,9: 323-330.
  • 8Kawaguchi A, Gandjbakhch I, Pavie A, et al. Cardiac transplantation recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options. Circulation , 1989, 80:90-96.
  • 9Fischer LG, Van Aken H, Bruken H, et al. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg, 2003,96:1603-1616.
  • 10Haverich A, Dammenhayn L, Albes J, et al, Heart transplantation:intraoperative management, postoperative therapy and complications.Thorac Cardiovasc Surgeon, 1990,38: 280-284.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部